Navigation Links
Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients

that results of clinical trials are not predictive of safety and efficacy results of Soliris in broader patient populations, the risk that third parties won't agree to license any necessary intellectual property to us on reasonable terms, the risk that third party payors will not reimburse for the use of Soliris at acceptable rates or at all, the risk that Soliris will not generate interest among physicians, the risk that estimates regarding the number of PNH patients are inaccurate, the risk that pending litigation may be resolved adversely, and a variety of other risks set forth from time to time in Alexion's filings with the Securities and Exchange Commission, including but not limited to the risks discussed in Alexion's Quarterly Report on Form 10-Q for the period ended March 31, 2007 and in our other filings with the Securities and Exchange Commission. Alexion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof, except when a duty arises under law.

1 Hillmen P. The Terminal Complement Inhibitor Eculizumab Reduces Thrombosis in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH). Study accepted for presentation at the 12th Congress of European Hematology, organized by The European Hematology Association (EHA), on Saturday, June 9 in Vienna, Austria.

2 Schrezenmeier H. Safety and Efficacy of the Terminal Complement Inhibitor Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): SHEPHERD Phase III Clinical Study Results. Study accepted for presentation at the 12th Congress of European Hematology, organized by The European Hematology Association (EHA), on Saturday, June 9 in Vienna, Austria.

3 Muus P. The Clinical Benefit of Eculizumab is Demonstrable in All Subpopulations of Patients with Paroxysmal Nocturnal Hemoglobinuira PNH with Hemolysis. Study accepted for oral presentation at the 12th Congress of European Hematology, organized by The European Hem
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
4. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
5. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
10. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
11. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
Post Your Comments:
(Date:7/7/2015)... , July 7, 2015  Shareholder rights ... that a federal securities fraud class action complaint ... the Southern District of California.  The complaint alleges ... CLDN ) violated the Securities Exchange Act ... 25, 2015, by making materially false and misleading ...
(Date:7/7/2015)... 7, 2015 Berger & Montague, P.C., ... law firm with one of the largest and ... co-counsel Faruqi and Faruqi, LLP in settling three ... AstraZeneca Pharmaceuticals LP, Cephalon, Inc., and Biogen, Inc., ... fees.  Under the agreements, AstraZeneca will pay the ...
(Date:7/7/2015)... Kalifornien, 7. Juli 2015 Sequent ... sich der Entwicklung innovativer Geräte für die ... Zugang von R. Michael Kleine ... Herr Kleine verfügt über eine mehr als ... Gesundheitsfürsorge. Er hat verschiedene globale biomedizinische Unternehmen ...
Breaking Medicine Technology:Robbins Arroyo LLP: Celladon Corporation (CLDN) Misled Shareholders According to a Recently Filed Class Action 2Robbins Arroyo LLP: Celladon Corporation (CLDN) Misled Shareholders According to a Recently Filed Class Action 3AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 2AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to Resolve False Claims Act Allegations Made By Whistleblower Ronald Streck 3Sequent Medical beruft Mike Kleine in den Aufsichtsrat 2Sequent Medical beruft Mike Kleine in den Aufsichtsrat 3
... Clinical Therapeutic Cancer... -- TUEBINGEN, Germany, September 21, 2010 ... ... ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var ...
... MOUNTAIN VIEW, Calif., Sept. 21 VIVUS, Inc. (Nasdaq: ... from a two-year study of QNEXA® (phentermine/topiramate) Controlled Release ... condition that affects approximately one-third of adult Americans. ... (OB-305), a 52-week extension study for a subset of ...
Cached Medicine Technology:immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 2immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 3immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 4immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 5immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 6immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 7immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 8immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 9immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 10New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years 2New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years 3New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years 4New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years 5New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years 6
(Date:7/7/2015)... Dallas, TX (PRWEB) , ... July 07, 2015 , ... Ticket Down is a reputable ... Panama vs. Haiti and the United States vs. Honduras at the Toyota Stadium. ... today, July 7th at Toyota Stadium. The tournament, being held on American soil, will ...
(Date:7/7/2015)... CA (PRWEB) , ... July 07, 2015 , ... ... Business Times highlights rumors about possible facial rejuvenation that have emerged about Hillary ... former U.S. Secretary of State looks more youthful than she has in some ...
(Date:7/7/2015)... ... 2015 , ... The United States Centers for Disease Control and Prevention have ... Multicultural AIDS Coalition $3.78 million for a five-year HIV prevention partnership that ... and transgender women, the groups at highest risk of HIV infection in the ...
(Date:7/7/2015)... ... July 07, 2015 , ... Celestix Networks, the leading ... CelestixFederated VA Series virtual appliances. These virtual platforms expand the existing physical ... have proven to simplify the on-premises deployment of unified remote access and single ...
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois cannabis cultivation ... limited to permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) board and ... and are committed to making sure patients have access to cannabis as a ...
Breaking Medicine News(10 mins):Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2
... that the enzyme, endothelin converting enzyme-2 (ECE-2), may cause ... in Alzheimer,s disease and contribute to progression of the ... Williams PhD Scholar and colleagues at the University of ... issue [July 2009] of the American Journal of ...
... Jude technique yields clues about brain cells targeted by faulty single-strand DNA ... , , MEMPHIS, Tenn., July 27 Switching off ... to smaller brain size as well as problems in brain structures vital ... Jude Children,s Research Hospital scientists. , , The work, ...
... , , PORTLAND, ... Kiwok Nordic AB as the winner in the Humanitarian Impact ... for its BodyKom Series remote ECG monitor. Deployed in conjunction ... live independently while their heart is monitored through a reliable ...
... July 27 Olympus Managed Health Care Inc., a leading ... announced today that it has been awarded a license from ... (TPA) services to health plans, providers and other payor organizations ... Olympus Managed Health Care currently provides a wide range of ...
... , , OAKLAND, Calif., ... eating, will become the first large health care provider in the country ... a recent study showed that patrons chose healthier options when menus are ... study, conducted by the University of California at Berkeley,s Center for Weight ...
... , , Trinitas Comprehensive Cancer ... has new oral chemotherapy program in place , ... oral chemotherapy for treating a variety of cancers--along with projections from the ... be in oral form by 2013--raise questions for both clinicians and patients ...
Cached Medicine News:Health News:Blood flow in Alzheimer's disease 2Health News:Scientists Track Impact of DNA Damage in the Developing Brain 2Health News:Scientists Track Impact of DNA Damage in the Developing Brain 3Health News:Scientists Track Impact of DNA Damage in the Developing Brain 4Health News:Itanium Solutions Alliance Selects Sweden's Kiwok as the 2009 Innovation Awards Winner for Humanitarian Impact 2Health News:Itanium Solutions Alliance Selects Sweden's Kiwok as the 2009 Innovation Awards Winner for Humanitarian Impact 3Health News:Itanium Solutions Alliance Selects Sweden's Kiwok as the 2009 Innovation Awards Winner for Humanitarian Impact 4Health News:Itanium Solutions Alliance Selects Sweden's Kiwok as the 2009 Innovation Awards Winner for Humanitarian Impact 5Health News:Itanium Solutions Alliance Selects Sweden's Kiwok as the 2009 Innovation Awards Winner for Humanitarian Impact 6Health News:Kaiser Permanente to Provide Calorie, Nutrition Information on Cafeteria Menus 2Health News:Kaiser Permanente to Provide Calorie, Nutrition Information on Cafeteria Menus 3Health News:Kaiser Permanente to Provide Calorie, Nutrition Information on Cafeteria Menus 4Health News:Oral Chemotherapy Offers Patients a More Convenient, Less Invasive Treatment Option 2Health News:Oral Chemotherapy Offers Patients a More Convenient, Less Invasive Treatment Option 3
... system for performing fast, clean, safe and ... is microprocessor controlled to automatically spin CenSlide ... minute. At the end of the cycle, ... the viewing area for microscopic analysis.,The CenSlide ...
Used to provide drainage of urine from the bladder. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open packages. Inte...
... temporary internal drainage from the ... Supplied sterile in peel-open packages. ... Periodic evaluation is advised; polyurethane, ... not remain indwelling more than ...
... temporary internal drainage from ... the bladder in pediatric ... peel-open packages. Intended for ... evaluation is advised; stent ...
Medicine Products: